Transfusion Thresholds, Quality of Life, and Current Approaches in Myelodysplastic Syndromes
Hemoglobin thresholds and triggers for blood transfusions have changed over the years moving from a higher to a lower level. This review article summarizes the current evidence of transfusion thresholds in the hospitalized as well as in the outpatient setting and particularly in myelodysplasia. Fati...
Saved in:
Main Author: | Ioannis Koutsavlis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Anemia |
Online Access: | http://dx.doi.org/10.1155/2016/8494738 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myelodysplastic Syndrome with Transfusion Dependence Treated with Venetoclax
by: Waqas Jehangir, et al.
Published: (2020-01-01) -
Red Blood Cell Transfusion Independence Following the Initiation of Iron Chelation Therapy in Myelodysplastic Syndrome
by: Maha A. Badawi, et al.
Published: (2010-01-01) -
Myelodysplastic Syndrome and Autoimmunity: A Case Report of an Unusual Presentation of Myelodysplastic Syndrome
by: Andrea L. Merrill, et al.
Published: (2011-01-01) -
Imetelstat as a novel therapeutic approach for myelodysplastic syndrome
by: Ammara Waheed Arain, et al.
Published: (2025-01-01) -
Iron Chelation Therapy in Myelodysplastic Syndromes
by: Emanuela Messa, et al.
Published: (2010-01-01)